The England licensing scheme for non-surgical cosmetic procedures: a practitioner's timeline

For years, "regulation is coming" was the sector's weather forecast: always imminent, never arriving. That has changed. England now has a confirmed licensing scheme design, a completed public consultation, a parliamentary committee pressing for speed, and, as of June 2026, draft regulations for the highest-risk tier out for consultation. The question is no longer whether, but when, and in what order.

This article sets out the timeline as it stands in July 2026, what each tier means, and what a practitioner can usefully do now.

2022: the legal foundation

Section 180 of the Health and Care Act 2022 gave the Secretary of State the power to introduce a licensing regime for non-surgical cosmetic procedures in England. Two licences are envisaged: a personal licence for the practitioner, and a premises licence for the place where procedures are carried out. The power sat on the statute book while the detail was worked out.

2023: the first consultation

In September 2023, the Department of Health and Social Care consulted on the scope of the scheme, which procedures should be covered, who should be permitted to perform them, and how risk should be graded. The consultation proposed the structure that has since been confirmed: a traffic-light classification of procedures by risk.

August 2025: the consultation response, the scheme confirmed

On 7 August 2025, DHSC published its response to the 2023 consultation, drawing on 11,848 responses. The headline: the traffic-light scheme is going ahead. Its confirmed shape:

Two further decisions matter for every clinic. First, an age restriction: the procedures in scope will be restricted to patients aged 18 and over, extending the approach Parliament took with the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021. Second, the amber tier's oversight requirement puts a named, regulated healthcare professional on the hook for non-healthcare practitioners' work, a role that will demand exactly the consent, delegation and record-keeping infrastructure many businesses currently lack.

February 2026: Parliament pushes for pace

The Women and Equalities Committee reported in February 2026, pressing the government to move faster. The committee's concern was straightforward: every year of delay is another year in which high-risk procedures are performed without licensing, and another cohort of patients harmed in settings no regulator has inspected. The political pressure is now for acceleration, not delay.

June 2026: draft regulations for the red tier

The government has sequenced implementation by risk. Consultation on draft regulations for the highest-risk, red, procedures opened in June 2026, covering the procedures that will move into CQC-registered settings under regulated healthcare professionals. The government has committed to implementing the scheme within this Parliament.

The realistic timeline for amber and green

Red goes first because the harm is worst there. For the amber tier, which is where botulinum toxin and dermal fillers sit, and therefore where most of the sector lives, the machinery still has to be built: regulations drafted and consulted on, local-authority licensing schemes stood up, standards for training and premises finalised, and the oversight framework for non-healthcare practitioners defined. A realistic reading puts amber and green rollout across 2026–2027 and beyond, with red-tier restrictions biting first.

That sounds like breathing room. It is better read as preparation time, because licence applications will ask for evidence, and evidence takes months to accumulate, not days.

What to prepare now

The precise application requirements are not yet published. But the direction is unmistakable, and four categories of evidence will almost certainly be at the centre of any licensing assessment:

• A consent system that stands on its own. Treatment-specific consent documentation, a structured consultation and cooling-off process, and a clear line of sight to Montgomery and McCulloch. Licensing regimes inspect processes, not intentions.
• Record-keeping you could hand over tomorrow. Contemporaneous notes, before-and-after photographs, batch numbers, complication logs, organised, retrievable, retained. If a licensing officer asked for a patient journey end to end, could you print it?
• Training evidence. Certificates, CPD records, complication-management training including hyaluronidase protocols where relevant. The amber tier's oversight model will make demonstrable competence a condition of practice, not a marketing point.
• Insurance aligned with the rules. Cover that matches what you actually do, with policy conditions, photographic records, retention periods, that you demonstrably meet. An insurer's conditions and a licensing scheme's standards will increasingly point at the same paperwork.

Here is the practical truth of the transition: practitioners who can already evidence their standards will experience licensing as an administrative step, forms, fees, an inspection that confirms what they were doing anyway. Practitioners who cannot will experience it as a wall. The scheme does not create the gap between those two groups; it makes the gap visible, and then it makes it commercial.

Getting licence-ready without building it yourself

Everything in the preparation list above is documentation and process work, the exact work Cleritas does. The done-for-you consent system builds the consultation framework, treatment-specific consent suite, cooling-off protocol and record-keeping standards end to end, so that when the application window opens, your evidence already exists.

See what a done-for-you consent system includes →

Related reading: what Montgomery actually requires · why claims are lost on paperwork · the consent audit